The pharmaceutical landscape is undergoing a paradigm shift driven by Artificial Intelligence (AI) and Machine Learning (ML). This paper explores the transition from traditional empirical methods to data-driven discovery, focusing on drug design, clinical trials, and patient-centric healthcare delivery. By integrating predictive modeling and advanced computational architectures, the pharmaceutical industry is transitioning from serendipity-driven discovery to targeted, high-throughput precision medicine [1].
Keywords: Artificial Intelligence (AI); Machine Learning (ML); Drug Discovery; Computational Drug Design; Deep Learning; Natural Language Processing (NLP); Clinical Trials; Precision Medicine; Pharmaceutical Research and Development; Computer Vision; Drug Repurposing; Predictive Modeling; Healthcare Analytics; Pharmacoinformatics; AI-Driven Healthcare
| 2-5 Days | Initial Quality & Plagiarism Check |
| 25-35 Days |
Peer Review Feedback |
| 45-60 Days | Total article processing time |